Skip to main content

Chronic Lymphocytic Leukemia (CLL) Clinical Trials

Review the chronic lymphocytic leukemia (cll) clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 101-125 of 129

A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML
Status: Active
Location: See ClinicalTrials.gov
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Status: Active
Location: See ClinicalTrials.gov
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
Status: Active
Location: See ClinicalTrials.gov
Autologous CAR19.20.22 Chimeric Antigen Receptor T Cells (CAR19.20.22 CART) for the Treatment of Recurrent or Refractory B-Cell Lymphomas
Status: Enrolling by Invitation
Location: University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland
Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients with Chronic Lymphocytic Leukemia
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Venetoclax and Ibrutinib in Treating Patients with Chronic or Small Lymphocytic Leukemia
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Reduced-Intensity Conditioning for the Prevention of Treatment-Related Mortality in Patients who Undergo a Hematopoietic Stem Cell Transplant
Status: Temporarily Closed to Accrual
Location: Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)
Status: Temporarily Closed to Accrual
Location: See ClinicalTrials.gov
Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Status: Temporarily Closed to Accrual
Location: See ClinicalTrials.gov
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies
Status: Temporarily Closed to Accrual
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Universal Donor Natural Killer Cells in Combination with Aldesleukin and Vactosertib for the Treatment of Patients with Locally Advanced or Metastatic Colorectal, Gastric and Esophageal Cancers and Relapsed or Refractory Hematologic Cancers
Status: Temporarily Closed to Accrual
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Evaluation of Smartphone Wellness Apps for the Management of Sleep Disturbances in Patients with a Hematological Cancer
Status: Active
Location: 3 locations
Diet and Exercise Program to Improve Fatigue in Patients with Chronic Lymphocytic Leukemia, HEALTH4CLL2 Trial
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Personalized Exercise and Nutrition Programs to Improve Cancer-Related Fatigue in Patients with Indolent Lymphoma
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
Status: Active
Location: 5 locations
Anti-pneumococcal Vaccine Strategy in Patients with Chronic Lymphocytic Leukemia
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Post-Transplant Cyclophosphamide for the Prevention of Graft Versus Host Disease in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning for Hematological Diseases
Status: Active
Location: University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Status: Active
Location: City of Hope Comprehensive Cancer Center, Duarte, California
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
Status: Active
Location: 2 locations
Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T
Status: Enrolling by Invitation
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Predictors of Health-Related Quality of Life in Adults with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status: Active
Location: Moffitt Cancer Center, Tampa, Florida
Implementation of a Medication Adherence Intervention for Chronic Leukemia Patients (Aim 3)
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Vaccine Responses in Patient with Multiple Myeloma and Non-Hodgkin Lymphoma after CAR-T Treatment
Status: Active
Location: OHSU Knight Cancer Institute, Portland, Oregon
Collecting Blood Samples from Patients with and without Cancer to Evaluate Tests for Early Cancer Detection
Status: Active
Location: 721 locations
realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL
Status: Active
Location: 7 locations